Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia

Summary

RATIONALE: Levofloxacin may be effective in reducing fever and controlling other symptoms of neutropenia in patients who are being treated for cancer. It is not yet known whether levofloxacin is more effective than cefepime in reducing fever and controlling symptoms of neutropenia. PURPOSE: Randomized phase III trial to compare the effectiveness of levofloxacin with that of cefepime in reducing fever and controlling symptoms of neutropenia in patients who are being treated for cancer.

Timeline

Start

2001-09

Primary completion

—

Completion

—

Drugs

Indications